News / Information - Wellbutrin (bupropion hydrochloride) 75 mg Tablets Discontinuation
Mar 01, 2016
0173-0177-55
Effective immediately, GlaxoSmithKline (GSK) will discontinue Wellbutrin (bupropion hydrochloride) 75 mg Tablets in bottles of 100s.
This website is funded and developed by GSK. This site is intended for US healthcare professionals only.
Trademarks are owned by or licensed to the GSK group of companies.
©2019 GSK group of companies or its licensor. Produced in USA.